Cox models for OS and EFS
Variable . | Multivariable analyses . | |||
---|---|---|---|---|
OS . | EFS . | |||
HR (95% CI) | P | HR (95% CI) | P | |
Age* | 1.06 (1.00-1.14) | .05 | 1.07 (1.02-1.12) | < .01 |
IgG myeloma | 0.60 (0.26-1.34) | .21 | 0.52 (0.28-0.96) | .03 |
International Staging System 3 | 1.91 (0.74-4.90) | .18 | 1.53 (0.73-3.20) | .26 |
Disease in remission† at allografting | 0.20 (0.06-0.67) | .01 | 0.33 (0.17-0.65) | < .01 |
HCT-specific comorbidity index ≥ 3 | 0.96 (0.27-3.36) | .95 | 0.87 (0.33-2.28) | .78 |
Variable . | Multivariable analyses . | |||
---|---|---|---|---|
OS . | EFS . | |||
HR (95% CI) | P | HR (95% CI) | P | |
Age* | 1.06 (1.00-1.14) | .05 | 1.07 (1.02-1.12) | < .01 |
IgG myeloma | 0.60 (0.26-1.34) | .21 | 0.52 (0.28-0.96) | .03 |
International Staging System 3 | 1.91 (0.74-4.90) | .18 | 1.53 (0.73-3.20) | .26 |
Disease in remission† at allografting | 0.20 (0.06-0.67) | .01 | 0.33 (0.17-0.65) | < .01 |
HCT-specific comorbidity index ≥ 3 | 0.96 (0.27-3.36) | .95 | 0.87 (0.33-2.28) | .78 |